NLS Pharmaceutics (NLSP) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
NLS Pharmaceutics AG, a Kloten-based stock corporation, has announced its share capital details, revealing a capital band with an upper limit of CHF 3,979,498.80. The board is authorized to increase share capital at any time until November 8, 2029, potentially issuing up to 1,658,124 fully paid common shares. Investors interested in pharmaceutical development might find this an intriguing opportunity for portfolio diversification.
For further insights into NLSP stock, check out TipRanks’ Stock Analysis page.